期刊文献+

小儿神经母细胞瘤的临床分析 被引量:18

Clinical analysis of neuroblastoma in children
原文传递
导出
摘要 目的探讨小儿神经母细胞瘤的诊断和治疗。方法结合相关文献对我科经手术治疗的80例小儿神经母细胞瘤患儿的临床资料进行回顾性分析,男54例,女26例,来源于肾上腺36例,交感神经节44例(其中腹膜后20例,纵膈12例,颈部12例),47例无远处转移的患儿先手术切除瘤体(含1例IVs期患儿),后多药联合化疗,33例远处发生转移活检病理结果明确为神经母细胞瘤后给予术前化疗,待转移灶消失后给予手术治疗,术后多药联合化疗。结果80例手术患儿行根治性切除72例,姑息性切除8例,完全切除视野内瘤体的比率为90%。术中行血管修补4例,其中腹主动脉1例,下腔静脉3例。64例随访患儿生存38例,Ⅰ期、Ⅱ期、Ⅲ期共28例,Ⅳ期8例,ⅣS期2例。3例术后复发再次行手术治疗,术后继续给予化疗,现生存良好,2例带瘤生存。结论神经母细胞瘤恶性程度高,诊断时瘤体多已侵及主要血管,手术技巧对于神经母细胞瘤的治疗至关重要,完全切除视野内的瘤体对于提高神经母细胞瘤患儿的生存率有很大的作用。对于远处发生转移患儿先行穿刺,病理结果明确为神经母细胞瘤后给予术前化疗,待转移灶消失后给予手术治疗。神经母细胞瘤如能做到早期诊断、及时手术加规律化疗等综合治疗,预后相对较好。 Objective To explore the clinical characteristics of neuroblastoma in children. Methods The clinical data of 80 children with neuroblastoma were analyzed. And the relevant litera- tures were reviewed. There were 54 males and 26 females. The sources were from adrenal gland (n = 36) and sympathetic ganglion (n = 44). Forty-seven cases which the other parts were not invaded were first operated and then chemotherapeutics were taken,the other were opposite. Results All of them underwent surgery. Among them, neuroblastoma was completely removed in 72 patients and partially removed in 8. Vascular repair was performed in 4 patients. During follow-ups, among 64 cases, 16 patients became lost, 38 survived cases and another 3 required reoperation due to postoperative re lapse. Conclusions The malignancy of neuroblastoma is high and its surgical techniques are crucial for optimal management. Complete resection may increase the survival rate. And a better prognosis is a- chieved if it can be early diagnosed and treated timely.
出处 《中华小儿外科杂志》 CSCD 北大核心 2014年第2期100-103,共4页 Chinese Journal of Pediatric Surgery
关键词 神经母细胞瘤 诊断 外科手术 回顾性研究 TNeuroblastoma Diagnosis Surgical procedures,operative Retrospective studies
  • 相关文献

参考文献15

  • 1Kevin Y,Julie V. Birth characteristics and risk of neuroblastoma in young children[J].{H}American Journal of Epidemiology,2007,(5):486-495.
  • 2Kubota M. The role of surgery in the treatment of neuroblastoma[J].{H}SURGERY TODAY-THE JAPANESE Journal OF SURGERY,2010,(6):526-532.
  • 3London WB,Boni L,Simon T. The role of age in neuroblastoma risk stratification:the German,Italian,and children's oncology group perspectives[J].{H}CANCER LETTERS,2005,(1-2):257-266.
  • 4张莉华,谢文晖,俞志昌.1500例肺癌患者核素骨显像结果分析[J].中华核医学杂志,1999,19(1):6-7. 被引量:43
  • 5Mc Gregor LM,Rao BN,Davidoff AM. The impact of early resection of primary neuroblastoma on the survival of children older than 1 years of age with stage 4 diseases:the St.Jude children's research hospital experience[J].{H}CANCER,2005,(12):2837-2846.
  • 6Pearson AD,Pinkerton CR,Lewis U. High-dose rapid and standard induction chemotherapy for patients aged over1 year with stage 4 neuroblastoma:a randomised trial[J].{H}LANCET ONCOLOGY,2008,(3):247-256.
  • 7Kiely E. A technique for excision of abdominal and pelvic neuroblastoma[J].{H}Annals of the Royal College of Surgeons of England,2007,(4):342-348.
  • 8Parodi F,Passonli L,Massimo L. Identification of novel prognostic markers in relapsing localized referable neuroblastoma[J].{H}OMICS A JOURNAL OF INTEGRATIVE BIOLOGY,2011,(3):113-121.
  • 9Bagatell R,Beck-Popovie M,London WB. Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma1:A report from the International Neuroblastoma Risk Group database[J].{H}Journal of Clinical Oncology,2009,(3):365-370.
  • 10Tsuchida Y,Yokoyama J,Kaneko M. Therapeutic significance of surgery in advanced neuroblastoma:A report from the study group of Japan[J].Pediutr Surg,1992,(5):616-622.

二级参考文献10

  • 1[1]Holland JF, Bast RC, Morton DL, et al. Cancer Medicine. in:Robertc. seeger ed, Neuroblastoma [ J ]. Williams & Wilkins, 1998,55633.
  • 2[2]Cotterill SJ, Pearson AD, Pritchard J, et al. Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group ‘Survey' 1982 - 1992 [ J].Eur J Cancer, 2000, 36(7): 901 - 908.
  • 3[3]Bowman IC, Hancock ML, Santana VM, et al. Impact of intensified therapy on clinical outcome in infants and children with neuroblastoma. the St Jude Children's Research Hospital Experience, 1962-1988 [J]. J Clin Oncol, 1991, 9: 1599-1608.
  • 4[4]Bernard JL, Philip T, Zucker JM, et al. Sequential cisplatin/VM-26 and vincristine/cyclophosphamide/doxorubicin in metastatic neuroblastoma: an effective alternating non-crossresistant regimen? [ J ]. J Clin Oncol, 1987, 5 (12): 1952 - 1959.
  • 5[5]Kushner BH, La quaglia MP, Bonilla MA, et al. Highly effectiv induction therapy for stage 4 neuroblastoma in children over 1 year of age [J]. J Clin Oncol, 1994,12:2607 - 2613.
  • 6[6]Matthay KK, Villablanca JG, Seeger RC, et al. Treatment of highrisk neuroblastoma with intensive chemotherapy, radiotherapy,autologous bone marrow transplantation, and 13-cis-retinoic acid.Children's Cancer Group [J] . N Engl J Med, 1999, 341(16):1165 - 1173.
  • 7[7]Cheung NK, Kushner BH, Cheung IY, et al. Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age [J] . J Clin Oncol, 1998,16(9): 3053 -3060.
  • 8[8]Garaventa A, Bellagamba O, Lo Piccolo MS, et al. 131 I-metaiodobenzylguanidine (131 I-MIBG) therapy for residual neuroblastoma: a mono-institutional experience with 43 patients [J]. Br J Cancer,1999,81 (8): 1378 - 1384.
  • 9徐昌文,肺癌,1993年,43页
  • 10马寄晓,实用临床核医学,1990年,240页

共引文献46

同被引文献124

引证文献18

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部